Picture of Jaguar Health logo

JAGX — Jaguar Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Jaguar Health Inc reports results for the quarter ended in March - Earnings Summary

* Jaguar Health Inc  JAGX.OQ  reported a quarterly adjusted
loss
of 40 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 17
cents per share.
    * Revenue rose 111.5% to $2.63 million from a year ago; 
analysts
expected $1.62 million. 
    * Jaguar Health Inc's reported EPS for the quarter was a
loss
of 40 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Jaguar Health Inc shares had fallen by 43.6% this
quarter and
lost 61.5% so far this year.
    * The company reported a quarterly loss of $17.99 million.
    * Wall Street's median 12-month price target for Jaguar
Health Inc
is $10.88 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 05:15 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Jaguar Health

See all news